Pharmaceutical

Roche wins first approval for subcutaneous Tecentriq

The subcutaneous Tecentriq has been approved in the UK for all indications that its intravenous counterpart has received approval.

Aug 30, 2023 - 20:00
Roche wins first approval for subcutaneous Tecentriq
The subcutaneous Tecentriq has been approved in the UK for all indications that its intravenous counterpart has received approval.
Read the original article

Tags:

Previous Article

Codagenix pursues RSV vaccine development amid unexpected challenges

Next Article

Signal: PureHealth UK expansion shows continued focus on healthcare in UAE

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

STAT+: Pharmalittle: CVS to overhaul how it’s paid for drugs; Biden drug-shortage plan won’t expand chemo supplies

STAT+: Pharmalittle: CVS to overhaul how it’s paid for ...

Dec 5, 2023

South Korea seeks to accelerate drug reimbursement administration process

South Korea seeks to accelerate drug reimbursement admi...

Jun 22, 2024

NImmune and BioTherapeutics partner on precision medicine development

NImmune and BioTherapeutics partner on precision medici...

Sep 8, 2024